Axon Enterprise, Inc. (NASDAQ:AXON) Given Average Rating of "Buy" by Brokerages – MarketBeat


Axon Enterprise, Inc. (NASDAQ:AXON) has been given a consensus recommendation of “Buy” by the six ratings firms that are currently covering the stock, Marketbeat Ratings reports. Two investment analysts have rated the stock with a hold rating and four have given a buy rating to the company. The average 1-year price target among analysts that have issued ratings on the stock in the last year is $183.50.

A number of equities research analysts have weighed in on AXON shares. JPMorgan Chase & Co. downgraded shares of Axon Enterprise from an “overweight” rating to a “neutral” rating and lifted their price target for the stock from $129.00 to $179.00 in a research note on Friday, February 12th. Northland Securities started coverage on shares of Axon Enterprise in a research note on Friday, February 26th. They set a “buy” rating and a $170.00 price target on the stock. Zacks Investment Research downgraded shares of Axon Enterprise from a “buy” rating to a “hold” rating in a research note on Tuesday, March 2nd. Morgan Stanley started coverage on shares of Axon Enterprise in a research note on Monday, February 1st. They set an “overweight” rating and a $185.00 price target on the stock. Finally, Robert W. Baird lifted their price target on shares of Axon Enterprise from $135.00 to $200.00 and gave the stock an “outperform” rating in a research note on Friday, February 26th.

Shares of Axon Enterprise stock opened at $137.82 on Friday. The company’s fifty day simple moving average is $162.77 and its 200-day simple moving average is $50.28. The company has a market cap of $8.79 billion, a price-to-earnings ratio of -66.90 and a beta of 1.21. The company has a current ratio of 2.02, a quick ratio of 2.02 and a debt-to-equity ratio of 1.24. Axon Enterprise has a 1 year low of $60.55 and a 1 year high of $212.37.

READ  1,500 Brockton educators will receive COVID vaccine through health center partnership - Enterprise News

Axon Enterprise (NASDAQ:AXON) last announced its quarterly earnings data on Wednesday, February 24th. The biotechnology company reported $1.00 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.36 by $0.64. As a group, research analysts forecast that Axon Enterprise will post -1.27 earnings per share for the current fiscal year.

In other Axon Enterprise news, Director Matthew R. Mcbrady sold 1,060 shares of Axon Enterprise stock in a transaction on Friday, March 12th. The stock was sold at an average price of $152.63, for a total transaction of $161,787.80. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, CFO Jawad A. Ahsan sold 20,200 shares of Axon Enterprise stock in a transaction on Friday, March 12th. The shares were sold at an average price of $152.11, for a total value of $3,072,622.00. Following the transaction, the chief financial officer now directly owns 131,481 shares of the company’s stock, valued at $19,999,574.91. The disclosure for this sale can be found here. Over the last three months, insiders have sold 80,601 shares of company stock valued at $12,206,707. Company insiders own 6.00% of the company’s stock.

Axon Enterprise Company Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy weapons (CEWs) worldwide. The company operates through two segments, TASER and Software and Sensors. It offers TASER X26P, TASER X2, TASER 7, and TASER Pulse and Bolt CEWs; and related cartridges. The company also provides on-officer body cameras and Axon Fleet in-car video systems; and Axon Evidence connected software network; Axon Records cloud-based records management system; Axon Signal enabled devices; and computer-aided dispatch software, as well as Axon docks, cartridges, and batteries.

READ  LIVE: Riot police brace for more pro-Trump riots - Park Rapids Enterprise

Further Reading: How to Profit and Limit Losses With Stop Orders

Analyst Recommendations for Axon Enterprise (NASDAQ:AXON)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat’s editorial team prior to publication. Please send any questions or comments about this story to [email protected]

10 Cheap Dividend Stocks to Buy Today

While COVID-19 was a sucker-punch to the stock market earlier in the year, the stock market is roaring back.  The Dow now over 30,000, and the S&P 500 is trading above 3,700. S&P 500 stocks are trading at nearly 23 times their annual earnings, still well above historical norms.

At the same time, interest rates are near all-time lows (and probably dipping even lower). 10-year Treasuries are yielding just 0.9%, and collectively S&P 500 stocks are yielding under 2%. Some investors think that it’s too challenging to find safe and affordable securities that pay 4%, 5%, and even 6% yields.

Searching for yield isn’t easy in an environment where historically high asset prices and stimulus from the Fed have driven down yields. This doesn’t leave many options for investors looking for retirement income or a decent dividend yield on their stocks, but there are a handful of cheap dividend stocks to buy that are still yielding 3-6%. 

Let’s review some of the best cheap dividend stocks in the market today in this slideshow.

View the “10 Cheap Dividend Stocks to Buy Today”.



READ SOURCE

LEAVE A REPLY

Please enter your comment!
Please enter your name here